Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_3
1
33%
Ph phase_1
2
67%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 3Large-scale testing
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Not yet recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 12 (66.7%)
Phase 31 (33.3%)

Trials by Status

not_yet_recruiting267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_3

A Study of HS-10506 in Chinese Patients With Insomnia Disorder

NCT07587385
not_yet_recruitingphase_1

Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder

NCT06279286
unknownphase_1

Phase 1a Study in Healthy Participants

NCT05953506

Clinical Trials (3)

Showing 3 of 3 trials
NCT07587385Phase 3

A Study of HS-10506 in Chinese Patients With Insomnia Disorder

Not Yet Recruiting
NCT06279286Phase 1

Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder

Not Yet Recruiting
NCT05953506Phase 1

Phase 1a Study in Healthy Participants

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3